MOR Stock Summary and Trading Ideas (Morphosys Ag - American Depositary Shares | NASDAQ:MOR)

MorphoSys AG is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases. MorphoSys is advancing its own pipeline of new drug candidates and has created antibodies that are developed by partners in different areas of unmet medical need. Tremfya (guselkumab) - developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc. for the treatment of plaque psoriasis - became the first drug based on MorphoSys antibody technology to receive regulatory approval. The U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi (tafasitamab-cxix) in combination with lenalidomide for patients with a certain type of lymphoma.

Morphosys Ag - American Depositary Shares trades on the NASDAQ stock market under the symbol MOR.

As of April 19, 2024, MOR stock price declined to $17.98 with 180,698 million shares trading.

MOR has a beta of 0.30, meaning it tends to be less sensitive to market movements. MOR has a correlation of 0.00 to the broad based SPY ETF.

MOR has a market cap of $2.70 billion. This is considered a Mid Cap stock.

Last quarter Morphosys Ag - American Depositary Shares reported $64 million in Revenue and $.33 earnings per share. This fell short of revenue expectation by $-4 million and exceeded earnings estimates by $.24.

In the last 3 years, MOR stock traded as high as $24.19 and as low as $3.17.

The top ETF exchange traded funds that MOR belongs to (by Net Assets): IBB, APIE, DFIC.

MOR has outperformed the market in the last year with a price return of +247.8% while the SPY ETF gained +21.2%. MOR has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +96.1% and -0.6%, respectively, while the SPY returned +3.0% and -4.5%, respectively.

MOR support price is $17.96 and resistance is $18.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MOR stock will trade within this expected range on the day.